Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities
This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov
describes (7)
Related CVEs.
| ID | severity | exploitable | ||
|---|---|---|---|---|
| CVE-2015-3956US | critical9.8OT elevated | — | ||
Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, f… | ||||
| CVE-2015-3954US | critical9.8 | — | ||
Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated use… | ||||
| CVE-2015-3953US | critical9.8OT elevated | — | ||
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, versi… | ||||
| CVE-2015-3952US | high7.5OT elevated | — | ||
Wireless keys are stored in plain text on Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, versi… | ||||
| CVE-2015-3958US | high7.8 | — | ||
Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a denial of service (forced manual reboot) via a flood of TCP pa… | ||||
| CVE-2015-3957US | medium4.6OT elevated | — | ||
Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors. | ||||
| CVE-2015-3955US | high10.0 | — | ||
Stack-based buffer overflow in Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to execute arbitrary code via unspecified… | ||||
references
External citations — patches, advisories, analysis.
- ICS Advisory ICSA-15-161-01 JSONself
- Recommended Practicesexternal
- ICS Advisory ICSA-15-161-01 - Web Versionself
- Recommended Practicesexternal
- Recommended Practicesexternal
- Recommended Practicesexternal
- Recommended Practicesexternal
- Recommended Practicesexternal
remediations (21)
- MitigationPlum A+ Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+ Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+ Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+ Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+ Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+ Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+ Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+3 Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+3 Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+3 Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+3 Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+3 Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+3 Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+3 Infusion System
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
Advisories like this name the exposed products attackers go after on your perimeter. See what is exposed on your perimeter with a free passive scan.
Free scan